Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 2—February 2019
Dispatch

Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India

Maria Koshy, Manjeera Jagannati, Ravikar Ralph, Punitha Victor, Thambu David, Sowmya Sathyendra, Balaji Veeraraghavan, and George M. VargheseComments to Author 
Author affiliations: Christian Medical College, Vellore, India

Main Article

Table 2

Bivariate analysis of predictors of mortality from melioidosis, southern India, 2008–2014

Predictors of mortality Alive, n = 97 Dead, n = 17 Odds ratio (95% CI) p value
Diabetes mellitus 79 14 0.94 (0.23–3.62) 0.92
Harmful ethanol use 14 2 0.90 (0.18–4.43) 0.89
Chronic kidney disease 3 1 0.45 (0.04–4.65) 0.5
Tachypnea, reference >24/min 12 12 16.8 (5.03–53.11) <0.001
Tachycardia, reference >100/min 22 11 6.16 (2.04–18.57) 0.001
Hypotension, reference <90/60 mmHg 4 7 16.10 (4.00–64.70) <0.001
Sequential organ failure assessment score 1 (0–3) 4 (2–8) 1.4 (1.1–1.7) <0.001
Bacteremia 47 16 17.02 (2.17–133.43) 0.007
Respiratory involvement 19 9 4.61 (1.57–13.55) 0.005
Hypoalbuminemia, reference <3 g/dL 38 13 4.02 (1.21–13.33) 0.02
Intensive care unit admission 12 13 23.02 (6.44–82.24) <0.001
Mechanical ventilation 8 13 36.15 (9.52–137.23) <0.001

Main Article

Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external